New Key Statistics Module, Z-Score and F-Score
NAS:AVDL Key Ratios
| Market Cap $ M | 1,076.36 |
| Enterprise Value $ M | 1,012.49 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 23.25 |
| Price/Book | 14.41 |
| Price/Sales | 7.63 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 138.00 |
| EPS (TTM) $ | -0.76 |
| Beneish M-Score | 11.05 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -16.19 |
| EV-to-EBITDA | -16.73 |
| PEG | -- |
| Shares Outstanding M | 96.36 |
| Net Margin (%) | -52.53 |
| Operating Margin % | -46.33 |
| Pre-tax Margin (%) | -52.84 |
| Quick Ratio | 2.60 |
| Current Ratio | 2.97 |
| ROA % (ttm) | -42.62 |
| ROE % (ttm) | -86.15 |
| ROIC % (ttm) | -116.24 |
| Dividend Yield % | -- |
| Altman Z-Score | 0.95 |
AVDL Number of Guru Trades
AVDL Volume of Guru Trades
Gurus Latest Trades with NAS:AVDL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:AVDL is held by these investors
Total 1
Avadel Pharmaceuticals PLC Insider Transactions
No Available Data
News about NAS:AVDL
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers